Tiziana Life Sciences (TLSA) Reports Positive Phase 2a Clinical Data Tiziana Life…
Stock Price Wednesday Morning Newsletter – September 4, 2019
Browsing Category
Biotechnology
143 posts
Tiziana Life Sciences (TLSA) Reports Positive Phase 2a Clinical Data Exhibiting Positive Clinical Activity with Milciclib Monotherapy in Advanced Sorafenib-refractory or -intolerant Patients with Unresectable or Metastatic Hepatocellular Carcinoma
NEW YORK–(BUSINESS WIRE)– Tiziana Life Sciences plc (TLSA), a biotechnology company focusing…
Top 3 Biotech Stocks to Watch For September?
Biotech stocks and the biotech sector in general have been one of…
Is Amgen (AMGN)’s Acquisition of Celgene’s Medicine A Boost For Biotech Stocks?
When it comes to the biggest pharmaceutical companies in the world, then…
PharmaCyte Biotech (PMCB) Confirms Dr. Manuel Hidalgo Will Be Principal Investigator for Clinical Trial in Pancreatic Cancer
LAGUNA HILLS, Calif.–(BUSINESS WIRE)– PharmaCyte Biotech, Inc. (PMCB), a biotechnology company focused…
3 Biotech Stocks To Watch In September
It is a well-known fact that pharmaceutical companies from all over the…
Stock Price Newsletter – August 26, 2019
Multi-Billion Dollar Markets Are Ready For A Shake-Up; 1 Biotech Stock Could…
3 Biotech Stocks To Watch This Month
Cancer is the most damaging health risk for millions of people worldwide,…
PharmaCyte Biotech to Hold Special Shareholder Meeting
LAGUNA HILLS, Calif.–(BUSINESS WIRE)– PharmaCyte Biotech, Inc. (PMCB), a clinical-stage biotechnology company…
GT Biopharma (GTBP) Hires Chief Medical Officer Jeffery Miller, M.D.
TAMPA, FL / ACCESSWIRE / August 20, 2019 / GT Biopharma, Inc. (GTBP)…